Pages that link to "Q34546440"
Jump to navigation
Jump to search
The following pages link to A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer (Q34546440):
Displaying 50 items.
- Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages (Q21092323) (← links)
- Adjuvant therapy for resected pancreatic cancer (Q24186323) (← links)
- Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer (Q24240739) (← links)
- Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer (Q24245085) (← links)
- Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer (Q24337345) (← links)
- Recent progress in pancreatic cancer (Q24626346) (← links)
- miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor (Q24628906) (← links)
- Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759] (Q24792780) (← links)
- Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283]. (Q24816432) (← links)
- How Grim is Pancreatic Cancer? (Q26740598) (← links)
- Pancreatic Cancer from Molecular Pathways to Treatment Opinion (Q26743482) (← links)
- Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question? (Q26746031) (← links)
- Deciphering the role of hedgehog signaling in pancreatic cancer (Q26747103) (← links)
- Pancreatic cancer from bench to bedside: molecular pathways and treatment options (Q26747524) (← links)
- A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma (Q26748880) (← links)
- Diagnostic Laparoscopy with Ultrasound Still Has a Role in the Staging of Pancreatic Cancer: A Systematic Review of the Literature (Q26749301) (← links)
- Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review (Q26765288) (← links)
- Neoadjuvant radiotherapeutic strategies in pancreatic cancer (Q26766686) (← links)
- Prognostic and predictive markers in pancreatic adenocarcinoma (Q26771965) (← links)
- Management of pancreatic cancer in the elderly (Q26774639) (← links)
- Viro-immune therapy: A new strategy for treatment of pancreatic cancer (Q26774641) (← links)
- Adjuvant therapy for pancreas cancer in an era of value based cancer care (Q26775916) (← links)
- Surgery for oligometastasis of pancreatic cancer (Q26781546) (← links)
- GEMMs as preclinical models for testing pancreatic cancer therapies (Q26781848) (← links)
- Proton therapy for pancreatic cancer (Q26784227) (← links)
- Novel agents for advanced pancreatic cancer (Q26787087) (← links)
- Irreversible electroporation and the pancreas: What we know and where we are going? (Q26795522) (← links)
- Perspectives in the treatment of pancreatic adenocarcinoma (Q26797248) (← links)
- Novel adjuvant therapies for pancreatic adenocarcinoma (Q26799425) (← links)
- Neoadjuvant therapy for localized pancreatic cancer: guiding principles (Q26799428) (← links)
- Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies (Q26799714) (← links)
- Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma (Q26801411) (← links)
- Neoadjuvant therapy for pancreas cancer: past lessons and future therapies (Q27004292) (← links)
- Pancreatic adenocarcinoma: treating a systemic disease with systemic therapy (Q27008346) (← links)
- Systemic therapies for pancreatic cancer--the role of pharmacogenetics (Q27021716) (← links)
- Ampullary cancer: an overview (Q27023881) (← links)
- Pancreatic cancer treatment and research: an international expert panel discussion (Q27690868) (← links)
- Genetic factors affecting patient responses to pancreatic cancer treatment (Q28075293) (← links)
- New challenges in perioperative management of pancreatic cancer (Q28082422) (← links)
- Clinical Management of Pancreatic Cancer (Q28084173) (← links)
- Advances in chemotherapy for pancreatic cancer (Q28085711) (← links)
- Update on the management of pancreatic cancer: surgery is not enough (Q28087060) (← links)
- BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation (Q28293407) (← links)
- Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer (Q28534413) (← links)
- Reversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cells (Q28534611) (← links)
- EMT and dissemination precede pancreatic tumor formation (Q29615854) (← links)
- Pancreatic cancer (Q29622871) (← links)
- A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review (Q30238706) (← links)
- Pancreatic cancer: yesterday, today and tomorrow. (Q30250026) (← links)
- Adjuvant Trametinib Delays the Outgrowth of Occult Pancreatic Cancer in a Mouse Model of Patient-Derived Liver Metastasis (Q30277400) (← links)